InsidersTradesSigma
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Rothfuss Cristin. Director active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 5 filings have been published. History available since 26 November 2024. The latest transaction was disclosed on 10 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations